Exact Sciences | EXAS - Loan Capital

Stock Price
53.74
Daily Change
-0.07 -0.13%
Monthly
31.36%
Yearly
-8.59%
Q3 Forecast
53.36

Exact Sciences reported $2.32B in Loan Capital for its fiscal quarter ending in June of 2025.



Financials
Stock Price USD
Assets USD 5.8B
Cash and Equivalent USD 657.1M
Cost of Sales USD 248.63M
Current Assets USD 1.51B
Current Liabilities USD 521.93M
Debt USD 2.32B
EBIT USD -2.15M
EBITDA USD 138.22M
Employees 6.9K
EPS Earnings Per Share USD -0.01
Equity Capital and Reserves USD 2.47B
Gross Profit on Sales USD 562.45M
Interest Expense on Debt USD 9.84M
Interest Income USD -5.29
Loan Capital USD 2.32B
Market Capitalization USD 9.96B
Net Income USD -1.19M
Operating Expenses USD 813.23M
Operating Profit USD -2.15M
Ordinary Share Capital USD 189.22M
Pre-Tax Profit USD -57K
Sales Revenues USD 811.1M
Selling and Administration Expenses USD 455.7M
Stock USD 171.5M
Trade Creditors USD 157.32M
Trade Debtors USD 353.34M

Loan Capital Change Date
Agilent USD 3.35B 1000K Jul/2025
Becton, Dickinson and Co. USD 17.53B 135M Jun/2025
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.2B 400K Jun/2025
Bruker USD 2.38B 303.5M Jun/2025
Charles River Laboratories USD 2.33B 178.38M Jun/2025
Danaher USD 16.85B 877M Jun/2025
Exact Sciences USD 2.32B 9.48M Jun/2025
Hologic USD 2.51B 37.5M Jun/2025
Illumina USD 1.49B 1000K Jun/2025
Mettler Toledo International USD 2.12B 232.49M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Quidel USD 2.07B 33.8M Jun/2025
Repligen USD 533.72M 4.12M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
STAAR Surgical USD 0 0 Mar/2025
Thermo Fisher Scientific USD 33.02B 1.64B Jun/2025
Veracyte USD 0 0 Mar/2025
Waters USD 1.2B 159.76M Jun/2025